EXOZ
EXOZYMES INC.
NASDAQ · Healthcare · Biotechnology · US
$4.45
−6.32%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$4.80
From 52W high−73.03%
Volume12188.00
Market cap$41.41M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$4.80
From 52W high
−73.03%
Volume
12188.00
Market cap
$41.41M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.5x
P/E (TTM)
—
RSI (14)
50.9
MomentumView details →
1D Return
−6.32%
YTD Return
−56.47%
SummaryUpdated Jun 1, 2026
eXoZymes, Inc. (NASDAQ:EXOZ) is a synthetic biochemical company founded in 2014 and headquartered in Monrovia, California. The company went public in November 2024, representing a relatively new entrant to the public markets in the biotechnology sector. eXoZymes focuses on developing platform technologies for producing various chemicals through biological processes, positioning itself at the intersection of biotechnology and industrial chemistry.
Similar companies
Latest newsMore news →
eXoZymes announced that CEO Michael Heltzen will participate in a Water Tower Research fireside chat on October 22, 2026, at 11 a.m. Eastern time.14d agoWater Tower Research published an Initiation of Coverage Report on eXoZymes, Inc. (NASDAQ: EXOZ), titled "Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity".33d agoeXoZymes Inc. announced an agreement with Curia Global, Inc. to initiate commercial-scale manufacturing of its NCT product, with the program expected to commence in Q4 2026 and a roadmap for larger-scale production in 2027.57d ago